WIM
MR

Waverton Investment Management’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Waverton Investment Management’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-63,930
Closed -$2.07M – 167
2014
Q1 		$2.07M Hold
63,930
– – 0.1% 137
2013
Q4 		$2.32M Hold
63,930
– – 0.12% 129
2013
Q3 		$2.49M Buy
+63,930
New +$2.58M 0.15% 125

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Waverton Investment Management's MR Position: Q2 2014 in Review

Waverton Investment Management sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q2 2014, closing a stake of 63,930 shares — an estimated $2.07M sold.

Waverton Investment Management first reported a position in MR in Q3 2013 and held it in 3 quarters. The position peaked at $2.49M in Q3 2013. 131 funds tracked by Wall St. Rank hold MR as of Q2 2014.

  • Waverton Investment Management reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q2 2014 after selling out during the quarter.
  • Waverton Investment Management sold 63,930 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q2 2014, an estimated $2.07M.
  • Waverton Investment Management first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q3 2013 and held it in 3 quarters.
  • Waverton Investment Management's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $2.49M in Q3 2013.
  • 131 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q2 2014.

Based on Waverton Investment Management's 13F filing for Q2 2014, filed 28 Jul 2014.